25 results
8-K
EX-10.1
AFIB
Acutus Medical Inc
9 Nov 23
Entry into a Material Definitive Agreement
6:41pm
be expected to last for more than three months; (ii) a recall which could reasonably be expected to result in aggregate liability to the Borrower
8-K
EX-10.1
AFIB
Acutus Medical Inc
1 Jul 22
Entry into a Material Definitive Agreement
6:47am
Product, which discontinuance, withdrawal or delay could reasonably be expected to last for more than three months; (ii) a recall which could
8-K
EX-2.1
AFIB
Acutus Medical Inc
27 Apr 22
Acutus Medical Announces Agreements to Fund Strategic Growth Priorities
6:30am
liability to the Seller or any voluntary or involuntary recall of any Seller Products, or similar written correspondence or written notice from the FDA … ) credits or allowances given or made for rejection, recall, return or wastage replacement, or for rebates or retroactive price reductions;
(c) price
8-K
EX-99.2
cobcjnozxf60gdrzl8o
12 Nov 21
Acutus Medical Reports Third Quarter 2021 Financial Results
5:16pm
424B4
shok48h
15 Jul 21
Prospectus supplement with pricing info
4:50pm
DRS
e7uek1unor3moksbo
27 May 21
Draft registration statement
12:00am
10-K
bz2rr jh9du3eir
19 Mar 21
Annual report
12:00am
424B4
8l2yb79v vwczop4sqf
7 Aug 20
Prospectus supplement with pricing info
12:00am
S-1
o6d8dtdo8imm3jem
15 Jul 20
IPO registration
4:53pm
S-1
EX-10.3
i62w1
15 Jul 20
IPO registration
4:53pm
S-1
EX-10.5
6dr4y1g9g
15 Jul 20
IPO registration
4:53pm
S-1
EX-10.1
ufu3h ie5kv
15 Jul 20
IPO registration
4:53pm
S-1
EX-10.4
9j883te6bb6fes9hv
15 Jul 20
IPO registration
4:53pm
S-1
EX-2.1
drua3lwx9
15 Jul 20
IPO registration
4:53pm
DRS/A
EX-10.5
q5jxdflspd
29 Jun 20
Draft registration statement (amended)
12:00am
DRS/A
ahvw1 mpeu
29 Jun 20
Draft registration statement (amended)
12:00am